Northern Territory Consolidated Acts

[Index] [Table] [Search] [Search this Act] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

MEDICINES, POISONS AND THERAPEUTIC GOODS ACT 2012 - SECT 243F

Access for relevant prescribers and pharmacists

    (1)     The CHO may, on application, authorise a person who is a relevant prescriber or pharmacist to access, use and disclose information held in the monitored medicines database for the following purposes in the performance of the person's duties as a relevant prescriber or pharmacist:

        (a)     accessing records and information in relation to a person for whom a monitored medicine is intended to be supplied, prescribed or administered;

        (b)     accessing records and information in relation to a person in relation to the medical treatment or care of that person;

        (c)     disclosing information in relation to a person to a health practitioner if the relevant prescriber or pharmacist believes, on reasonable grounds, the practitioner intends to supply, prescribe or administer a monitored medicine to the person;

        (d)     any other purpose prescribed by regulation.

    (2)     An application for authorisation must be made in the approved form by the person.

    (3)     The CHO may request further information from the person making the application.

    (4)     The CHO must consider the application and decide whether to give the authorisation.

    (5)     The CHO must give the person:

        (a)     written notice of the CHO's decision; and

        (b)     if the CHO refuses to give the authorisation – written notice of the reasons for the refusal.

    (6)     An authorisation given under this section may be subject to any conditions the CHO considers appropriate.

    (7)     The CHO may revoke an authorisation given under this section at any time by giving the person written notice of the revocation and the reasons for the revocation.

Note for section 243F

A relevant prescriber or pharmacist's access, use or disclosure of the information may be subject to guidelines made under section 243Q.



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback